Impact of Reducing Glycated Hemoglobin on Healthcare Costs Among a Population with Uncontrolled Diabetes

DiscussionIn our analysis, A1C reduction among patients with T1DM and T2DM was associated with slower growth in healthcare costs within 1 –2 years. These findings suggest that programs aimed at reducing A1C over a short timeframe may lead to substantial savings and may be worth pursuing by health plans and other payers.
Source: Applied Health Economics and Health Policy - Category: Health Management Source Type: research